Lonza, which is in process of acquiring one of the world’s largest biologics manufacturing plants from Roche for $1.2 billion, has hired Wolfgang Wienand to assume the role of CEO beginning this summer, replacing interim chief Albert Baehny.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,